GRAL

#1860

GRAIL, Inc. Common Stock

43.0600 USD

-2.89%

Сектор: Здравоохранение

Базовая: USD

Валюта прибыли: USD

Дневной диапазон

Годовой диапазон

Дневное изменение

-2.89%

Месячное изменение

-56.51%

6-месячное изменение

-56.51%

Годовое изменение

-56.51%

Предыдущее закрытие

44.3400

Open

43.0600

Bid

43.0600

Ask

43.0630

Low

43.0600

High

43.0600

Объем

Open full chart

Financials

Overview Отчетность Statistics

Quarterly Annual

Total assets 3.12 B2.98 B2.85 B2.7 B2.6 B2.92 B Total liabilities 530.32 M479.9 M433.94 M387.91 M361.07 M344.15 M Total equity 2.59 B2.5 B2.41 B2.31 B2.24 B2.58 B Total liabilities & shareholders' equities 3.12 B2.98 B2.85 B2.7 B2.6 B2.92 B Total debt —————— Net debt ——————

GRAIL Inc

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021. In June 2021 Galleri launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024.